Cart

YOUR CART IS EMPTY

Add research compounds to begin your order.

Peer-reviewed human trials and related publicationsSee approved evidence mapCompleted

Lancet

RET-STUDY-P005

Rosenstock J, et al. Retatrutide in type 2 diabetes. Lancet. 2023. DOI: 10.1016/S0140-6736(23)01053-X. PMID: 37385280. NCT04867785. https://pubmed.ncbi.nlm.nih.gov/37385280/

Study design

Record details

Design: Peer-reviewed human trials and related publications

Evidence record

Endpoints, findings, and limitations

Limitations

This study record is an evidence-index entry. Interpret the design, material, population or model, endpoints, findings, and limitations only within the linked approved source and compound evidence map; do not transfer outcomes across compounds, materials, cohorts, or models.

Reports and sources

Reference ledger

P005Peer-reviewed human trials and related publications

Lancet

Rosenstock J, et al. Retatrutide in type 2 diabetes. Rosenstock J, et al. Retatrutide in type 2 diabetes. Lancet. 2023. DOI: 10.1016/S0140-6736(23)01053-X. PMID: 37385280. NCT04867785. https://pubmed.ncbi.nlm.nih.gov/37385280/(2023). DOI: 10.1016/S0140-6736(23